DuoGenic StemCells Corporation, founded in 2018 in Taichung Science Park, specializes in efficient and standardized stem cell cultivation services. The company develops high-quality, certified stem cell culture media for both 2D and 3D applications, including mesenchymal stem cell culture media and human recombinant proteins. Key regulatory achievements encompass GMP certification, ISO 13485, and a second-class medical material license. Dedicated to innovation, DuoGenic is establishing mass production systems and advancing blood cell therapy programs for degenerative diseases through clinical trials.